Our results showed that IQGAP3 expression was positively correlated with immune checkpoint genes (PD1, PD-L1, B7-H3, TIM3) and most of the immune checkpoint-associated genes in gliomas, suggesting that IQGAP3 may be promising as a new immune checkpoint for gliomas. The gene discussed is HAVCR2; the disease is central nervous system cancer.